(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -0.80%-674.19K | -668.83K |
Payments to suppliers for goods and services | -3.19%-674.19K | ---653.33K |
Other cash payments from operating activities | ---- | ---15.5K |
Direct interest received | --36.26K | ---- |
Operating cash flow | 4.62%-637.93K | ---668.83K |
Investing cash flow | ||
Cash flow from continuing investing activities | -742.49%-1.86M | -220.72K |
Capital expenditure reported | -1,101.74%-1.58M | ---131.69K |
Net PPE purchase and sale | 69.70%-26.97K | ---89.03K |
Net other investing changes | ---250K | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | -742.49%-1.86M | ---220.72K |
Financing cash flow | ||
Cash flow from continuing financing activities | 6.82M | |
Net common stock issuance | ---- | --6.82M |
Cash from discontinued financing activities | ||
Financing cash flow | ---- | --6.82M |
Net cash flow | ||
Beginning cash position | --5.93M | ---- |
Current changes in cash | -142.11%-2.5M | --5.93M |
End cash Position | -42.11%3.43M | --5.93M |
Free cash from | -153.44%-2.25M | ---889.55K |
Accounting Standards | US-GAAP | US-GAAP |
No Data